AU1199092A - Use of annulated tetrahydropyridinacetic acid derivates for treating neurological diseases - Google Patents

Use of annulated tetrahydropyridinacetic acid derivates for treating neurological diseases

Info

Publication number
AU1199092A
AU1199092A AU11990/92A AU1199092A AU1199092A AU 1199092 A AU1199092 A AU 1199092A AU 11990/92 A AU11990/92 A AU 11990/92A AU 1199092 A AU1199092 A AU 1199092A AU 1199092 A AU1199092 A AU 1199092A
Authority
AU
Australia
Prior art keywords
tetrahydropyridinacetic
annulated
neurological diseases
treating neurological
acid derivates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11990/92A
Inventor
Dietrich Arndts
Walter Losel
Otto Roos
Gunter Schingnitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU1199092A publication Critical patent/AU1199092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
AU11990/92A 1991-02-13 1992-02-06 Use of annulated tetrahydropyridinacetic acid derivates for treating neurological diseases Abandoned AU1199092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4104257A DE4104257A1 (en) 1991-02-13 1991-02-13 USE OF ANALYZED TETRAHYDROPYRIDINE IGNESE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL ILLNESSES
DE4104257 1991-02-13

Publications (1)

Publication Number Publication Date
AU1199092A true AU1199092A (en) 1992-09-15

Family

ID=6424901

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11990/92A Abandoned AU1199092A (en) 1991-02-13 1992-02-06 Use of annulated tetrahydropyridinacetic acid derivates for treating neurological diseases

Country Status (6)

Country Link
AU (1) AU1199092A (en)
DE (1) DE4104257A1 (en)
IE (1) IE920451A1 (en)
IL (1) IL100927A0 (en)
WO (1) WO1992014465A1 (en)
ZA (1) ZA921039B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724384B1 (en) * 1994-09-14 1999-04-16 Cemaf NOVEL 3,4-DIHYDRO BETA-CARBOLINE DERIVATIVES OF MELATONIN AGONISTS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
CA2360740A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
JP2002539247A (en) * 1999-03-24 2002-11-19 ハーバー ブランチ オーシャノグラフィック インスティテューション インク． Use of the anti-inflammatory effect of manzamine
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US7384957B2 (en) * 2001-12-19 2008-06-10 H. Lundbeck A/S 3,4-dihydro-1H-isoquinolin-2-yl-derivatives
TW201038569A (en) * 2009-02-16 2010-11-01 Abbott Gmbh & Co Kg Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
US8710245B2 (en) 2009-12-04 2014-04-29 Psychogenics Inc. Multicyclic compounds and methods of use thereof
CN116514761A (en) 2016-07-29 2023-08-01 赛诺维信制药公司 Compounds, compositions and uses thereof
EP3490607A4 (en) 2016-07-29 2020-04-08 Sunovion Pharmaceuticals Inc. Compounds and compositions and uses thereof
CA3053903A1 (en) 2017-02-16 2018-08-23 Sunovion Pharmaceuticals Inc. Methods of treating schizophrenia
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
MX2020008537A (en) 2018-02-16 2021-01-08 Sunovion Pharmaceuticals Inc Salts, crystal forms, and production methods thereof.
KR20210139376A (en) 2019-03-14 2021-11-22 선오비온 파마슈티컬스 인코포레이티드 Salts of isochromanyl compounds, and crystalline forms thereof, methods of preparation, therapeutic uses and pharmaceutical compositions
KR20230003503A (en) 2020-04-14 2023-01-06 선오비온 파마슈티컬스 인코포레이티드 (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine for the treatment of neurological and psychiatric disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3021331A (en) * 1959-07-20 1962-02-13 Pfizer & Co C Azabenzopyridocolines
FR2455044A1 (en) * 1979-04-26 1980-11-21 Synthelabo PYRIDO-INDOLES AND THEIR APPLICATION IN THERAPEUTICS
IL86131A0 (en) * 1987-04-24 1988-11-15 Boehringer Ingelheim Kg Benzo-and thieno-3,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3827727A1 (en) * 1988-08-16 1990-02-22 Boehringer Ingelheim Kg ANALYZED TETRAHYDROPYRIDINE IGNESE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE OF SUCH CONNECTIONS FOR CARDIRO PROTECTION
CA2000901A1 (en) * 1988-10-21 1990-04-21 Alexis A. Cordi Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury
JPH03109385A (en) * 1989-09-22 1991-05-09 Fujisawa Pharmaceut Co Ltd New tricyclic amine compound and salt thereof
AU6368090A (en) * 1989-10-03 1991-04-11 Warner-Lambert Company Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity

Also Published As

Publication number Publication date
DE4104257A1 (en) 1992-08-20
ZA921039B (en) 1992-09-30
WO1992014465A1 (en) 1992-09-03
IE920451A1 (en) 1992-08-12
IL100927A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
EP0799617A3 (en) Therapeutic agent for neurological diseases
GB2305605B (en) Pipecolic acid derivatives for the treatment of neurological disorders
AU661018B2 (en) Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents
AU3738293A (en) Compounds useful for treating allergic and inflammatory diseases
AU1532492A (en) Use of heterocyclic compounds for the treatment of inflammatory pain
HUT53391A (en) Process for treatment of ground
AU1199092A (en) Use of annulated tetrahydropyridinacetic acid derivates for treating neurological diseases
AU659456B2 (en) Fatty acid treatment
AU6459596A (en) Methods of treatment of neurological diseases by interferon antagonists
IL98387A0 (en) Pyridyl-benzoic acid derivatives for treating leukotriene-related diseases
EP0473131A3 (en) Electrical stimulator for the treatment of female incontinence
AU656592B2 (en) Treatment of organic sulfonic acid
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU3673293A (en) Process for the preparation of cinnamic acid derivatives
AU8516891A (en) Acid treatment for decaffeination of coffee
AU5252793A (en) Therapeutic for gram-positive diseases of aquatic species
EP0419998A3 (en) Use of alkylphosphonic acid derivatives for the treatment of psoriasis
AU5018893A (en) Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
AU7167591A (en) Treatment of hsv
ZA914369B (en) Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases
AU608865B2 (en) Treatment of cerebral disorders
AU5503090A (en) Imidazodiazepines for the treatment of neurological symptons
AU1593792A (en) Treatment of mastitis
AU7999691A (en) Phthalamic acids and their isomers for treating leukotriene-related diseases